StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Wells Fargo Downgrades Amphastar Pharmaceuticals (AMPH) to Equal Weight
May 14, 2026 5:16 AM
Wells Fargo analyst Benjamin Burnett downgraded Amphastar Pharmaceuticals (NASDAQ: AMPH) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Downgrades
